MCR - Tudca_als

Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS).

PHASE

III

NCT Number

NCT03800524

DEFINITION

Pharmacological

SPONSOR

Istituto Clinico Humanitas